- Report
- May 2026
- 217 Pages
Italy
From €4397EUR$4,850USD£3,758GBP
- Report
- May 2026
- 218 Pages
Japan
From €4397EUR$4,850USD£3,758GBP
- Report
- May 2026
- 219 Pages
Malaysia
From €4397EUR$4,850USD£3,758GBP
- Report
- May 2026
- 220 Pages
Mexico
From €4397EUR$4,850USD£3,758GBP
- Report
- February 2026
- 150 Pages
Canada
From €4397EUR$4,850USD£3,758GBP
- Report
- February 2026
- 150 Pages
China
From €4397EUR$4,850USD£3,758GBP
- Report
- February 2026
- 150 Pages
Germany
From €4397EUR$4,850USD£3,758GBP
- Report
- February 2026
- 150 Pages
India
From €4397EUR$4,850USD£3,758GBP
- Report
- May 2025
- 150 Pages
Global
From €4397EUR$4,850USD£3,758GBP
- Report
- April 2025
- 150 Pages
Global
From €4397EUR$4,850USD£3,758GBP
- Report
- April 2025
- 150 Pages
Global
From €4397EUR$4,850USD£3,758GBP
- Report
- April 2025
- 150 Pages
Global
From €4397EUR$4,850USD£3,758GBP
- Report
- March 2025
- 150 Pages
Global
From €4397EUR$4,850USD£3,758GBP
- Report
- March 2025
- 150 Pages
Global
From €4397EUR$4,850USD£3,758GBP
- Report
- March 2025
- 150 Pages
Global
From €4397EUR$4,850USD£3,758GBP
- Report
- March 2025
- 150 Pages
Global
From €4397EUR$4,850USD£3,758GBP
- Report
- March 2025
- 150 Pages
Global
From €4397EUR$4,850USD£3,758GBP
- Report
- February 2025
- 150 Pages
Global
From €4397EUR$4,850USD£3,758GBP
- Report
- November 2024
- 150 Pages
Global
From €4397EUR$4,850USD£3,758GBP
- Report
- September 2024
- 150 Pages
Global
From €4397EUR$4,850USD£3,758GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more